Could a simple pill stop deadly clots in cancer patients?
NCT ID NCT07160686
Summary
This large trial aims to see if a daily pill called apixaban can prevent dangerous blood clots in people with advanced lung cancer who are receiving chemotherapy. About 1,456 patients will be randomly assigned to take either the real pill or a placebo (sugar pill) for six months alongside their cancer treatment. The goal is to determine if this convenient oral medication is a safe and effective way to reduce a common and serious complication of cancer care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOPROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Birmingham
Birmingham, B15 2TT, United Kingdom
Conditions
Explore the condition pages connected to this study.